As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.
17 Analysts have issued a Prime Medicine forecast:
17 Analysts have issued a Prime Medicine forecast:
Jun '25 |
+/-
%
|
||
Revenue | 4.96 4.96 |
741%
741%
|
|
Gross Profit | - - |
-
|
|
EBITDA | -197 -197 |
10%
10%
|
EBIT (Operating Income) EBIT | -204 -204 |
9%
9%
|
Net Profit | -199 -199 |
8%
8%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Head office | United States |
CEO | Keith Gottesdiener |
Employees | 234 |
Founded | 2019 |
Website | primemedicine.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.